Key result
Intravenous nitroglycerin resulted in a considerable reduction or abolition of ischemic episodes in 85% of patients with refractory rest angina pectoris.
Why the study?
Does intravenously administered nitroglycerin reduce ischemic episodes in patients with refractory rest angina pectoris?
Population
20 patients with refractory rest angina pectoris
Design
Case_series
Authors
Loading...
May warrant consideration in refractory rest angina but should not change practice; leaves open confirmation in randomized trials.
Observational (n=20)
Does intravenously administered nitroglycerin reduce ischemic episodes in patients with refractory rest angina pectoris?
Intravenous nitroglycerin effectively reduces ischemic episodes in refractory rest angina, likely through both hemodynamic improvements and direct coronary vasodilation.
Nicholas L. DePace (1982) conducted an observational in Refractory rest angina pectoris (n=20). Intravenous nitroglycerin was evaluated on Reduction or abolition in the number of ischemic episodes. Intravenous nitroglycerin resulted in a considerable reduction or abolition of ischemic episodes in 85% of patients with refractory rest angina pectoris.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: